[250 Pages Report] The global ACF supplements market is anticipated to reach US$ 384.5 Billion in 2032. The market is growing rapidly and is said to be valued at US$ 163.9 Billion in 2022 and will register at a significant CAGR of 8.9 % during the forecast period from 2022 to 2032.
The demand for ACF supplements is increasing due to innovation and expansion in dietary supplements and pharmaceutical products. ACF stands for animal-free component, also known as an animal-derived component-free supplement. Chemically defined ACF supplements are added to the protein-free cell culture media to initiate cell growth.
Report Attribute | Details |
---|---|
ACF Supplements Market Expected Market Value (2022) | US$ 163.9 Billion |
ACF Supplements Market Anticipated Forecast Value (2032) | US$ 384.5 Billion |
ACF Supplements Market Projected Growth Rate (2022-2032) | 8.9 % CAGR |
With the production of new biopharmaceuticals for therapeutic use and advancements in processing technology, the use of animal-derived components is under continuous scrutiny. The use of animal-derived components in cell culture has a higher risk of contamination such as HIV, BSE, Hepatitis, and BVD.
The global ACF supplements market, which is not of animal origin, is getting extensively popular and significant amongst the manufacturers of bio-therapeutics and biomolecules. The demand for ACF supplements is said to grow in the future as they are being aggressively researched for their use in dietary supplements and pharmaceutical products.
Worldwide, consumers are adopting the vegetarian lifestyle and going vegan due to environmental concerns, personal health, and animal welfare. This shift in preference supports the growth of the ACF supplements market, and the demand for ACF supplements is predicted to increase during the forecast period.
The higher rate of adoption of the ACF supplements due to their health benefits like the low risk of LDL, heart disease, diabetes, blood pressure, and cancer and the advent of social media platforms to share data so that it gains more visibility to the public positively impacts the sales of ACF supplements market. During the forecast period, the global ACF supplements market is said to be driven by the development of energy-rich offerings and clean label ingredients.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The ACF supplements market has received a lot of traction in the industry. The key factors responsible for the growth of the ACF supplements market are the growing development and invention of the pharmaceutical products and dietary supplements are encouraging the demand for ACF supplements and generating a lucrative scenario in the global ACF supplements market.
Owing to the increasing use of social media and other platforms, there is a growing awareness pertaining to animal rights and animal cruelty. This positively influences the growth of the ACF supplements market. This rising social media use has resulted in growing global shortages and price hikes of the supplements derived from animals, such as fetal bovine serum (FBS).
Eventually, this has resulted in more popularity of animal component-free and serum-free supplements, and this is more economical and cost-efficient. The global ACF supplements market growth will boom due to the rising awareness amongst the consumers of dietary supplements and pharmaceutical products and between the manufacturers of these products.
The sales of ACF supplements are also supported by more and more consumption of dietary supplements in western countries such as Canada, the U.S., Germany, the U.K., etc., and due to the adoption of western lifestyle the Eastern countries such as China, India, Brazil, Indonesia, etc., have additional market opportunities.
There is a rise in cases of heart problems, diabetes, cognitive impairment, etc.; this has resulted in consumers adopting dietary supplements to stay fit. This is boosting the sales of dietary supplements, and considering the trend for plant-based products and ingredients, the global ACF supplements market will propel during the forecast period.
The growth rate of the ACF supplements market is said to ascend owing to the expanding health and fitness industry and consumer preference for meat alternatives, increasing knowledge around the advantages of proteins and a protein-rich diet.
There is an excessive expense directed toward the research and development activities in the cell culture industry. This is enabling the invention of novel products in the ACF supplements market along with improved functionality such as compatibility with a wide variety of commercially available culture media and increased single-cell cloning efficiency of CHO cells media. ACF supplements comprise recombinant proteins and phenol red, without any animal components, hydrolysates, serum, L-glutamine, etc.
North America’s market share is higher in the global ACF supplements market, followed by Europe. This is due to the increasing awareness of health and fitness coupled with the higher adoption of vegetarianism. Additionally, consumers are aware of the intake of a nutritious diet and rising concerns related to weight management; these factors will contribute to the growth of the ACF supplements market in this region.
Asia Pacific is anticipated to experience considerable growth in the ACF supplements market during the forecast period owing to excess expenditure for developing natural ingredients, a rise in disposable income, and rapid urbanization. In the Asia Pacific, especially China is said to garner the highest growth rate in terms of production.
Region-wise, the ACF supplements market is anticipated to gain maximum opportunity during the forecast period, specifically in the emerging economies owing to a higher rate of adoption of dietary supplements and pharmaceutical products. The rising ACF supplements consumption is backed by the growing GDP, booming middle-income population, and rising purchasing power.
Some of the leading companies operating in the global ACF Supplements market include STEMCELL Technologies Inc., Kerry Inc., StemCell Inc., Xell AG, InVitria, ScienCell Research Laboratories, Inc., HiMedia Laboratories, ZenBio, Biological Industries, PeproTech, Inc.
These market players are focussed on establishing their presence through acquisitions and collaborations. The manufacturing facilities and distribution network of these players are strong across regions. In April 2022, Kerry Inc., a global taste and nutrition giant, announced that they had successfully acquired the U.S.-based Natreon, Inc., a known supplier of branded Ayurvedic botanical ingredients.
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 6.54% from 2022 to 2032 |
Base Year for Estimation | 2021 |
Historical Data | 2015-2021 |
Forecast Period | 2022-2032 |
Quantitative Units | Revenue in USD Billion and CAGR from 2022-2032 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global ACF supplements market is set to secure a CAGR of 6.54% by 2032.
North America is projected to lead the ACF supplements market in the forecast period.
STEMCELL Technologies Inc., Kerry Inc., StemCell Inc., Xell AG, InVitria, ScienCell Research Laboratories, Inc., HiMedia Laboratories, ZenBio, Biological Industries, PeproTech, Inc. and others are some of the renowned companies in the ACF supplements market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global ACF Supplements Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global ACF Supplements Market Analysis 2017-2021 and Forecast 2022-2032, By Form 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Form, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Form, 2022-2032 5.3.1. Dry 5.3.2. Liquid 5.4. Y-o-Y Growth Trend Analysis By Form, 2017-2021 5.5. Absolute $ Opportunity Analysis By Form, 2022-2032 6. Global ACF Supplements Market Analysis 2017-2021 and Forecast 2022-2032, By End-use 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By End-use, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By End-use, 2022-2032 6.3.1. Pharmaceutical 6.3.2. Dietary Supplements 6.4. Y-o-Y Growth Trend Analysis By End-use, 2017-2021 6.5. Absolute $ Opportunity Analysis By End-use, 2022-2032 7. Global ACF Supplements Market Analysis 2017-2021 and Forecast 2022-2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Region, 2017-2021 7.3. Current Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Region, 2022-2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia & Pacific 7.3.6. MEA 7.4. Market Attractiveness Analysis By Region 8. North America ACF Supplements Market Analysis 2017-2021 and Forecast 2022-2032, By Country 8.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 8.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Form 8.2.3. By End-use 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Form 8.3.3. By End-use 8.4. Key Takeaways 9. Latin America ACF Supplements Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Form 9.2.3. By End-use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Form 9.3.3. By End-use 9.4. Key Takeaways 10. Europe ACF Supplements Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Form 10.2.3. By End-use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Form 10.3.3. By End-use 10.4. Key Takeaways 11. East Asia ACF Supplements Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.2. By Form 11.2.3. By End-use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Form 11.3.3. By End-use 11.4. Key Takeaways 12. South Asia & Pacific ACF Supplements Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Thailand 12.2.1.3. Indonesia 12.2.1.4. Malaysia 12.2.1.5. Singapore 12.2.1.6. Australia 12.2.1.7. New Zealand 12.2.1.8. Rest of South Asia & Pacific 12.2.2. By Form 12.2.3. By End-use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Form 12.3.3. By End-use 12.4. Key Takeaways 13. MEA ACF Supplements Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Form 13.2.3. By End-use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Form 13.3.3. By End-use 13.4. Key Takeaways 14. Key Countries ACF Supplements Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Form 14.1.2.2. By End-use 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Form 14.2.2.2. By End-use 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Form 14.3.2.2. By End-use 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Form 14.4.2.2. By End-use 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Form 14.5.2.2. By End-use 14.6. U.K. 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Form 14.6.2.2. By End-use 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Form 14.7.2.2. By End-use 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Form 14.8.2.2. By End-use 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Form 14.9.2.2. By End-use 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Form 14.10.2.2. By End-use 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Form 14.11.2.2. By End-use 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Form 14.12.2.2. By End-use 14.13. India 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Form 14.13.2.2. By End-use 14.14. Thailand 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Form 14.14.2.2. By End-use 14.15. Indonesia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Form 14.15.2.2. By End-use 14.16. Malaysia 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Form 14.16.2.2. By End-use 14.17. Singapore 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Form 14.17.2.2. By End-use 14.18. Australia 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Form 14.18.2.2. By End-use 14.19. New Zealand 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Form 14.19.2.2. By End-use 14.20. GCC Countries 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2021 14.20.2.1. By Form 14.20.2.2. By End-use 14.21. South Africa 14.21.1. Pricing Analysis 14.21.2. Market Share Analysis, 2021 14.21.2.1. By Form 14.21.2.2. By End-use 14.22. Israel 14.22.1. Pricing Analysis 14.22.2. Market Share Analysis, 2021 14.22.2.1. By Form 14.22.2.2. By End-use 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Form 15.3.3. By End-use 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Kerry Inc. 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. StemCell Inc. 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Xell AG 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. InVitria 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. ScienCell Research Laboratories, Inc. 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. HiMedia Laboratories 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. ZenBio 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. Biological Industries 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. PeproTech, Inc. 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Food and Beverage Insights
View Reports